Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - ImmunoGen, Inc.Financial_Report.xls
EX-10.2 - EX-10.2 - ImmunoGen, Inc.a14-21112_1ex10d2.htm
EX-10.4 - EX-10.4 - ImmunoGen, Inc.a14-21112_1ex10d4.htm
EX-10.1 - EX-10.1 - ImmunoGen, Inc.a14-21112_1ex10d1.htm
EX-10.5 - EX-10.5 - ImmunoGen, Inc.a14-21112_1ex10d5.htm
EX-31.2 - EX-31.2 - ImmunoGen, Inc.a14-21112_1ex31d2.htm
EX-10.6 - EX-10.6 - ImmunoGen, Inc.a14-21112_1ex10d6.htm
EX-10.3 - EX-10.3 - ImmunoGen, Inc.a14-21112_1ex10d3.htm
EX-31.1 - EX-31.1 - ImmunoGen, Inc.a14-21112_1ex31d1.htm
10-Q - 10-Q - ImmunoGen, Inc.a14-21112_110q.htm

EXHIBIT 32

 

Certification

 

Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

 

(Subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code)

 

Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), each of the undersigned officers of ImmunoGen, Inc., a Massachusetts corporation (the “Company”), does hereby certify, to such officer’s knowledge, that:

 

The Quarterly Report for the period ended September 30, 2014 (the “Form 10-Q”) of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and the information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Dated: October 30, 2014

/s/ DANIEL M. JUNIUS

 

Daniel M. Junius

 

President, Chief Executive Officer

 

(Principal Executive Officer)

 

 

Dated: October 30, 2014

/s/ DAVID B. JOHNSTON

 

David B. Johnston

 

Executive Vice President, Chief Financial Officer

 

(Principal Financial and Accounting Officer)